Stay updated on Elranatamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page
- Check6 days agoChange DetectedStudy details, eligibility criteria, and locations appear unchanged; only minor formatting/layout changes are visible. There are no new or removed substantive elements related to the trial's description or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page shows a new site revision (v3.4.2) and removal of a prior funding/operating-status notice (v3.4.1); these are minor maintenance updates that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page now shows the study as Recruiting and adds many active recruitment locations worldwide. A government funding notice about NIH operations is also posted.SummaryDifference0.3%

- Check28 days agoChange DetectedThe study locations list was updated: Changchun, Jilin, China was added and Ostrava, Czechia was removed, changing the total number of locations to 85. The page also adds a glossary toggle and updates the revision to v3.4.0.SummaryDifference0.9%

- Check42 days agoChange DetectedAdded MagnetisMM-6 study details with full title, design, interventions, outcomes, start/completion dates, enrollment, and 86 locations. Deleted the previous MagnetisMM-6 entry describing the older study version.SummaryDifference1%

- Check56 days agoChange DetectedThe page now includes related topics: Multiple myeloma and MedlinePlus Genetics. This is a minor addition to related topics and does not affect core study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.